Cargando…
The paradigm of protein acetylation in Parkinson’s disease
Autores principales: | Yakhine-Diop, Sokhna M.S., Martínez-Chacón, Guadalupe, Uribe-Carretero, Elisabet, Niso-Santano, Mireia, González-Polo, Rosa A., Fuentes, José M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404488/ https://www.ncbi.nlm.nih.gov/pubmed/30762005 http://dx.doi.org/10.4103/1673-5374.250575 |
Ejemplares similares
-
Toxicity of Necrostatin-1 in Parkinson’s Disease Models
por: Alegre-Cortés, Eva, et al.
Publicado: (2020) -
Acetylome in Human Fibroblasts From Parkinson's Disease Patients
por: Yakhine-Diop, Sokhna M. S., et al.
Publicado: (2018) -
The dual role of necrostatin-1 in Parkinson’s disease models
por: Alegre-Cortés, Eva, et al.
Publicado: (2021) -
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2020) -
Loss of KEAP1 Causes an Accumulation of Nondegradative Organelles
por: Uribe-Carretero, Elisabet, et al.
Publicado: (2022)